HealthBeacon plc
HealthBeacon plc HBCNF Peers
See (HBCNF) competitors and their performances in Stock Market.
Peer Comparison Table: Medical - Healthcare Information Services Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| HBCNF | $0.50 | +2269.67% | 8.44M | -0.59 | -$0.85 | N/A |
| PMCUF | $170.06 | +4.52% | 17.76B | 278.79 | $0.61 | +0.11% |
| MTHRY | $6.76 | +1.35% | 9.18B | 33.80 | $0.20 | N/A |
| MTHRF | $12.95 | N/A | 8.79B | 31.59 | $0.41 | +0.01% |
| PANHF | $0.96 | +13.31% | 2.08B | 96.20 | $0.01 | +129.58% |
| CMPUY | $24.63 | +7.07% | 1.27B | 42.46 | $0.58 | +4.34% |
| PIAHY | $2.29 | +2.23% | 1.24B | 114.50 | $0.02 | +217.08% |
| CMPVF | $23.85 | +0.44% | 1.23B | 41.13 | $0.58 | +8.28% |
| RSLBF | $32.19 | +34.67% | 1.10B | 48.04 | $0.67 | +0.58% |
| CRWRF | $27.32 | +12.50% | 956.72M | 65.05 | $0.42 | +1.38% |
Stock Comparison
HBCNF vs PMCUF Comparison
HBCNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HBCNF stands at 8.44M. In comparison, PMCUF has a market cap of 17.76B. Regarding current trading prices, HBCNF is priced at $0.50, while PMCUF trades at $170.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HBCNF currently has a P/E ratio of -0.59, whereas PMCUF's P/E ratio is 278.79. In terms of profitability, HBCNF's ROE is -0.57%, compared to PMCUF's ROE of +0.48%. Regarding short-term risk, HBCNF is more volatile compared to PMCUF. This indicates potentially higher risk in terms of short-term price fluctuations for HBCNF.
HBCNF vs MTHRY Comparison
HBCNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HBCNF stands at 8.44M. In comparison, MTHRY has a market cap of 9.18B. Regarding current trading prices, HBCNF is priced at $0.50, while MTHRY trades at $6.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HBCNF currently has a P/E ratio of -0.59, whereas MTHRY's P/E ratio is 33.80. In terms of profitability, HBCNF's ROE is -0.57%, compared to MTHRY's ROE of +0.09%. Regarding short-term risk, HBCNF is more volatile compared to MTHRY. This indicates potentially higher risk in terms of short-term price fluctuations for HBCNF.
HBCNF vs MTHRF Comparison
HBCNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HBCNF stands at 8.44M. In comparison, MTHRF has a market cap of 8.79B. Regarding current trading prices, HBCNF is priced at $0.50, while MTHRF trades at $12.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HBCNF currently has a P/E ratio of -0.59, whereas MTHRF's P/E ratio is 31.59. In terms of profitability, HBCNF's ROE is -0.57%, compared to MTHRF's ROE of +0.09%. Regarding short-term risk, HBCNF is more volatile compared to MTHRF. This indicates potentially higher risk in terms of short-term price fluctuations for HBCNF.
HBCNF vs PANHF Comparison
HBCNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HBCNF stands at 8.44M. In comparison, PANHF has a market cap of 2.08B. Regarding current trading prices, HBCNF is priced at $0.50, while PANHF trades at $0.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HBCNF currently has a P/E ratio of -0.59, whereas PANHF's P/E ratio is 96.20. In terms of profitability, HBCNF's ROE is -0.57%, compared to PANHF's ROE of -0.00%. Regarding short-term risk, HBCNF is less volatile compared to PANHF. This indicates potentially lower risk in terms of short-term price fluctuations for HBCNF.
HBCNF vs CMPUY Comparison
HBCNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HBCNF stands at 8.44M. In comparison, CMPUY has a market cap of 1.27B. Regarding current trading prices, HBCNF is priced at $0.50, while CMPUY trades at $24.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HBCNF currently has a P/E ratio of -0.59, whereas CMPUY's P/E ratio is 42.46. In terms of profitability, HBCNF's ROE is -0.57%, compared to CMPUY's ROE of +0.04%. Regarding short-term risk, HBCNF is less volatile compared to CMPUY. This indicates potentially lower risk in terms of short-term price fluctuations for HBCNF.
HBCNF vs PIAHY Comparison
HBCNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HBCNF stands at 8.44M. In comparison, PIAHY has a market cap of 1.24B. Regarding current trading prices, HBCNF is priced at $0.50, while PIAHY trades at $2.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HBCNF currently has a P/E ratio of -0.59, whereas PIAHY's P/E ratio is 114.50. In terms of profitability, HBCNF's ROE is -0.57%, compared to PIAHY's ROE of -0.00%. Regarding short-term risk, HBCNF is more volatile compared to PIAHY. This indicates potentially higher risk in terms of short-term price fluctuations for HBCNF.
HBCNF vs CMPVF Comparison
HBCNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HBCNF stands at 8.44M. In comparison, CMPVF has a market cap of 1.23B. Regarding current trading prices, HBCNF is priced at $0.50, while CMPVF trades at $23.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HBCNF currently has a P/E ratio of -0.59, whereas CMPVF's P/E ratio is 41.13. In terms of profitability, HBCNF's ROE is -0.57%, compared to CMPVF's ROE of +0.04%. Regarding short-term risk, HBCNF is more volatile compared to CMPVF. This indicates potentially higher risk in terms of short-term price fluctuations for HBCNF.
HBCNF vs RSLBF Comparison
HBCNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HBCNF stands at 8.44M. In comparison, RSLBF has a market cap of 1.10B. Regarding current trading prices, HBCNF is priced at $0.50, while RSLBF trades at $32.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HBCNF currently has a P/E ratio of -0.59, whereas RSLBF's P/E ratio is 48.04. In terms of profitability, HBCNF's ROE is -0.57%, compared to RSLBF's ROE of +0.26%. Regarding short-term risk, HBCNF is less volatile compared to RSLBF. This indicates potentially lower risk in terms of short-term price fluctuations for HBCNF.
HBCNF vs CRWRF Comparison
HBCNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HBCNF stands at 8.44M. In comparison, CRWRF has a market cap of 956.72M. Regarding current trading prices, HBCNF is priced at $0.50, while CRWRF trades at $27.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HBCNF currently has a P/E ratio of -0.59, whereas CRWRF's P/E ratio is 65.05. In terms of profitability, HBCNF's ROE is -0.57%, compared to CRWRF's ROE of +0.04%. Regarding short-term risk, HBCNF is more volatile compared to CRWRF. This indicates potentially higher risk in terms of short-term price fluctuations for HBCNF.
HBCNF vs SUSRF Comparison
HBCNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HBCNF stands at 8.44M. In comparison, SUSRF has a market cap of 754.88M. Regarding current trading prices, HBCNF is priced at $0.50, while SUSRF trades at $14.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HBCNF currently has a P/E ratio of -0.59, whereas SUSRF's P/E ratio is 52.84. In terms of profitability, HBCNF's ROE is -0.57%, compared to SUSRF's ROE of +0.03%. Regarding short-term risk, HBCNF is more volatile compared to SUSRF. This indicates potentially higher risk in terms of short-term price fluctuations for HBCNF.
HBCNF vs SMSZF Comparison
HBCNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HBCNF stands at 8.44M. In comparison, SMSZF has a market cap of 727.28M. Regarding current trading prices, HBCNF is priced at $0.50, while SMSZF trades at $8.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HBCNF currently has a P/E ratio of -0.59, whereas SMSZF's P/E ratio is 17.47. In terms of profitability, HBCNF's ROE is -0.57%, compared to SMSZF's ROE of +0.20%. Regarding short-term risk, HBCNF is more volatile compared to SMSZF. This indicates potentially higher risk in terms of short-term price fluctuations for HBCNF.
HBCNF vs KSIOF Comparison
HBCNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HBCNF stands at 8.44M. In comparison, KSIOF has a market cap of 459.24M. Regarding current trading prices, HBCNF is priced at $0.50, while KSIOF trades at $4.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HBCNF currently has a P/E ratio of -0.59, whereas KSIOF's P/E ratio is -243.25. In terms of profitability, HBCNF's ROE is -0.57%, compared to KSIOF's ROE of -0.05%. Regarding short-term risk, HBCNF is more volatile compared to KSIOF. This indicates potentially higher risk in terms of short-term price fluctuations for HBCNF.
HBCNF vs VHIBF Comparison
HBCNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HBCNF stands at 8.44M. In comparison, VHIBF has a market cap of 393.87M. Regarding current trading prices, HBCNF is priced at $0.50, while VHIBF trades at $7.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HBCNF currently has a P/E ratio of -0.59, whereas VHIBF's P/E ratio is 243.17. In terms of profitability, HBCNF's ROE is -0.57%, compared to VHIBF's ROE of +0.02%. Regarding short-term risk, HBCNF is more volatile compared to VHIBF. This indicates potentially higher risk in terms of short-term price fluctuations for HBCNF.
HBCNF vs SMDCF Comparison
HBCNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HBCNF stands at 8.44M. In comparison, SMDCF has a market cap of 280.87M. Regarding current trading prices, HBCNF is priced at $0.50, while SMDCF trades at $17.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HBCNF currently has a P/E ratio of -0.59, whereas SMDCF's P/E ratio is -17.32. In terms of profitability, HBCNF's ROE is -0.57%, compared to SMDCF's ROE of N/A. Regarding short-term risk, HBCNF is more volatile compared to SMDCF. This indicates potentially higher risk in terms of short-term price fluctuations for HBCNF.
HBCNF vs DLHTF Comparison
HBCNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HBCNF stands at 8.44M. In comparison, DLHTF has a market cap of 254.80M. Regarding current trading prices, HBCNF is priced at $0.50, while DLHTF trades at $3.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HBCNF currently has a P/E ratio of -0.59, whereas DLHTF's P/E ratio is -17.24. In terms of profitability, HBCNF's ROE is -0.57%, compared to DLHTF's ROE of -0.24%. Regarding short-term risk, HBCNF is more volatile compared to DLHTF. This indicates potentially higher risk in terms of short-term price fluctuations for HBCNF.
HBCNF vs VPAHF Comparison
HBCNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HBCNF stands at 8.44M. In comparison, VPAHF has a market cap of 188.24M. Regarding current trading prices, HBCNF is priced at $0.50, while VPAHF trades at $0.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HBCNF currently has a P/E ratio of -0.59, whereas VPAHF's P/E ratio is -37.00. In terms of profitability, HBCNF's ROE is -0.57%, compared to VPAHF's ROE of -0.18%. Regarding short-term risk, HBCNF is more volatile compared to VPAHF. This indicates potentially higher risk in terms of short-term price fluctuations for HBCNF.
HBCNF vs COGZF Comparison
HBCNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HBCNF stands at 8.44M. In comparison, COGZF has a market cap of 150.20M. Regarding current trading prices, HBCNF is priced at $0.50, while COGZF trades at $0.88.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HBCNF currently has a P/E ratio of -0.59, whereas COGZF's P/E ratio is 22.00. In terms of profitability, HBCNF's ROE is -0.57%, compared to COGZF's ROE of +0.17%. Regarding short-term risk, HBCNF is more volatile compared to COGZF. This indicates potentially higher risk in terms of short-term price fluctuations for HBCNF.
HBCNF vs ONVVF Comparison
HBCNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HBCNF stands at 8.44M. In comparison, ONVVF has a market cap of 138.79M. Regarding current trading prices, HBCNF is priced at $0.50, while ONVVF trades at $0.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HBCNF currently has a P/E ratio of -0.59, whereas ONVVF's P/E ratio is -8.00. In terms of profitability, HBCNF's ROE is -0.57%, compared to ONVVF's ROE of -0.97%. Regarding short-term risk, HBCNF is less volatile compared to ONVVF. This indicates potentially lower risk in terms of short-term price fluctuations for HBCNF.
HBCNF vs ACMLF Comparison
HBCNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HBCNF stands at 8.44M. In comparison, ACMLF has a market cap of 130.74M. Regarding current trading prices, HBCNF is priced at $0.50, while ACMLF trades at $3.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HBCNF currently has a P/E ratio of -0.59, whereas ACMLF's P/E ratio is 30.33. In terms of profitability, HBCNF's ROE is -0.57%, compared to ACMLF's ROE of +0.21%. Regarding short-term risk, HBCNF is less volatile compared to ACMLF. This indicates potentially lower risk in terms of short-term price fluctuations for HBCNF.
HBCNF vs CSAMF Comparison
HBCNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HBCNF stands at 8.44M. In comparison, CSAMF has a market cap of 98.80M. Regarding current trading prices, HBCNF is priced at $0.50, while CSAMF trades at $4.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HBCNF currently has a P/E ratio of -0.59, whereas CSAMF's P/E ratio is -9.64. In terms of profitability, HBCNF's ROE is -0.57%, compared to CSAMF's ROE of -1.58%. Regarding short-term risk, HBCNF is more volatile compared to CSAMF. This indicates potentially higher risk in terms of short-term price fluctuations for HBCNF.
HBCNF vs MDPEF Comparison
HBCNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HBCNF stands at 8.44M. In comparison, MDPEF has a market cap of 61.28M. Regarding current trading prices, HBCNF is priced at $0.50, while MDPEF trades at $2.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HBCNF currently has a P/E ratio of -0.59, whereas MDPEF's P/E ratio is 6.00. In terms of profitability, HBCNF's ROE is -0.57%, compared to MDPEF's ROE of N/A. Regarding short-term risk, HBCNF is less volatile compared to MDPEF. This indicates potentially lower risk in terms of short-term price fluctuations for HBCNF.
HBCNF vs HITC Comparison
HBCNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HBCNF stands at 8.44M. In comparison, HITC has a market cap of 52.84M. Regarding current trading prices, HBCNF is priced at $0.50, while HITC trades at $0.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HBCNF currently has a P/E ratio of -0.59, whereas HITC's P/E ratio is -14.75. In terms of profitability, HBCNF's ROE is -0.57%, compared to HITC's ROE of -1.29%. Regarding short-term risk, HBCNF is more volatile compared to HITC. This indicates potentially higher risk in terms of short-term price fluctuations for HBCNF.
HBCNF vs RQHTF Comparison
HBCNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HBCNF stands at 8.44M. In comparison, RQHTF has a market cap of 29.76M. Regarding current trading prices, HBCNF is priced at $0.50, while RQHTF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HBCNF currently has a P/E ratio of -0.59, whereas RQHTF's P/E ratio is N/A. In terms of profitability, HBCNF's ROE is -0.57%, compared to RQHTF's ROE of -2.22%. Regarding short-term risk, HBCNF is less volatile compared to RQHTF. This indicates potentially lower risk in terms of short-term price fluctuations for HBCNF.
HBCNF vs RTNXF Comparison
HBCNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HBCNF stands at 8.44M. In comparison, RTNXF has a market cap of 22.55M. Regarding current trading prices, HBCNF is priced at $0.50, while RTNXF trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HBCNF currently has a P/E ratio of -0.59, whereas RTNXF's P/E ratio is -0.33. In terms of profitability, HBCNF's ROE is -0.57%, compared to RTNXF's ROE of +2.93%. Regarding short-term risk, HBCNF is less volatile compared to RTNXF. This indicates potentially lower risk in terms of short-term price fluctuations for HBCNF.
HBCNF vs VASO Comparison
HBCNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HBCNF stands at 8.44M. In comparison, VASO has a market cap of 22.31M. Regarding current trading prices, HBCNF is priced at $0.50, while VASO trades at $0.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HBCNF currently has a P/E ratio of -0.59, whereas VASO's P/E ratio is 12.70. In terms of profitability, HBCNF's ROE is -0.57%, compared to VASO's ROE of +0.04%. Regarding short-term risk, HBCNF is less volatile compared to VASO. This indicates potentially lower risk in terms of short-term price fluctuations for HBCNF.
HBCNF vs HDSLF Comparison
HBCNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HBCNF stands at 8.44M. In comparison, HDSLF has a market cap of 21.13M. Regarding current trading prices, HBCNF is priced at $0.50, while HDSLF trades at $0.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HBCNF currently has a P/E ratio of -0.59, whereas HDSLF's P/E ratio is -3.22. In terms of profitability, HBCNF's ROE is -0.57%, compared to HDSLF's ROE of -1.31%. Regarding short-term risk, HBCNF is more volatile compared to HDSLF. This indicates potentially higher risk in terms of short-term price fluctuations for HBCNF.
HBCNF vs TREIF Comparison
HBCNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HBCNF stands at 8.44M. In comparison, TREIF has a market cap of 19.04M. Regarding current trading prices, HBCNF is priced at $0.50, while TREIF trades at $0.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HBCNF currently has a P/E ratio of -0.59, whereas TREIF's P/E ratio is -2.74. In terms of profitability, HBCNF's ROE is -0.57%, compared to TREIF's ROE of -11.21%. Regarding short-term risk, HBCNF is less volatile compared to TREIF. This indicates potentially lower risk in terms of short-term price fluctuations for HBCNF.
HBCNF vs THKKF Comparison
HBCNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HBCNF stands at 8.44M. In comparison, THKKF has a market cap of 17.81M. Regarding current trading prices, HBCNF is priced at $0.50, while THKKF trades at $0.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HBCNF currently has a P/E ratio of -0.59, whereas THKKF's P/E ratio is -1.51. In terms of profitability, HBCNF's ROE is -0.57%, compared to THKKF's ROE of -0.61%. Regarding short-term risk, HBCNF is more volatile compared to THKKF. This indicates potentially higher risk in terms of short-term price fluctuations for HBCNF.
HBCNF vs DGNOF Comparison
HBCNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HBCNF stands at 8.44M. In comparison, DGNOF has a market cap of 17.62M. Regarding current trading prices, HBCNF is priced at $0.50, while DGNOF trades at $0.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HBCNF currently has a P/E ratio of -0.59, whereas DGNOF's P/E ratio is -5.76. In terms of profitability, HBCNF's ROE is -0.57%, compared to DGNOF's ROE of +2.18%. Regarding short-term risk, HBCNF is more volatile compared to DGNOF. This indicates potentially higher risk in terms of short-term price fluctuations for HBCNF.
HBCNF vs UDOCF Comparison
HBCNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HBCNF stands at 8.44M. In comparison, UDOCF has a market cap of 16.02M. Regarding current trading prices, HBCNF is priced at $0.50, while UDOCF trades at $0.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HBCNF currently has a P/E ratio of -0.59, whereas UDOCF's P/E ratio is -3.50. In terms of profitability, HBCNF's ROE is -0.57%, compared to UDOCF's ROE of +6.57%. Regarding short-term risk, HBCNF is less volatile compared to UDOCF. This indicates potentially lower risk in terms of short-term price fluctuations for HBCNF.
HBCNF vs MNNDF Comparison
HBCNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HBCNF stands at 8.44M. In comparison, MNNDF has a market cap of 14.25M. Regarding current trading prices, HBCNF is priced at $0.50, while MNNDF trades at $0.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HBCNF currently has a P/E ratio of -0.59, whereas MNNDF's P/E ratio is -1.48. In terms of profitability, HBCNF's ROE is -0.57%, compared to MNNDF's ROE of N/A. Regarding short-term risk, HBCNF is less volatile compared to MNNDF. This indicates potentially lower risk in terms of short-term price fluctuations for HBCNF.
HBCNF vs AIMLF Comparison
HBCNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HBCNF stands at 8.44M. In comparison, AIMLF has a market cap of 13.55M. Regarding current trading prices, HBCNF is priced at $0.50, while AIMLF trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HBCNF currently has a P/E ratio of -0.59, whereas AIMLF's P/E ratio is -1.95. In terms of profitability, HBCNF's ROE is -0.57%, compared to AIMLF's ROE of -11.81%. Regarding short-term risk, HBCNF is more volatile compared to AIMLF. This indicates potentially higher risk in terms of short-term price fluctuations for HBCNF.
HBCNF vs CRVW Comparison
HBCNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HBCNF stands at 8.44M. In comparison, CRVW has a market cap of 10.51M. Regarding current trading prices, HBCNF is priced at $0.50, while CRVW trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HBCNF currently has a P/E ratio of -0.59, whereas CRVW's P/E ratio is -1.80. In terms of profitability, HBCNF's ROE is -0.57%, compared to CRVW's ROE of +0.16%. Regarding short-term risk, HBCNF is more volatile compared to CRVW. This indicates potentially higher risk in terms of short-term price fluctuations for HBCNF.
HBCNF vs PBSV Comparison
HBCNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HBCNF stands at 8.44M. In comparison, PBSV has a market cap of 9.86M. Regarding current trading prices, HBCNF is priced at $0.50, while PBSV trades at $0.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HBCNF currently has a P/E ratio of -0.59, whereas PBSV's P/E ratio is -21.50. In terms of profitability, HBCNF's ROE is -0.57%, compared to PBSV's ROE of -0.00%. Regarding short-term risk, HBCNF is more volatile compared to PBSV. This indicates potentially higher risk in terms of short-term price fluctuations for HBCNF.
HBCNF vs HSCHF Comparison
HBCNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HBCNF stands at 8.44M. In comparison, HSCHF has a market cap of 9.50M. Regarding current trading prices, HBCNF is priced at $0.50, while HSCHF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HBCNF currently has a P/E ratio of -0.59, whereas HSCHF's P/E ratio is N/A. In terms of profitability, HBCNF's ROE is -0.57%, compared to HSCHF's ROE of +0.00%. Regarding short-term risk, HBCNF is more volatile compared to HSCHF. This indicates potentially higher risk in terms of short-term price fluctuations for HBCNF.
HBCNF vs VYND Comparison
HBCNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HBCNF stands at 8.44M. In comparison, VYND has a market cap of 9.16M. Regarding current trading prices, HBCNF is priced at $0.50, while VYND trades at $0.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HBCNF currently has a P/E ratio of -0.59, whereas VYND's P/E ratio is -24.99. In terms of profitability, HBCNF's ROE is -0.57%, compared to VYND's ROE of +0.48%. Regarding short-term risk, HBCNF is more volatile compared to VYND. This indicates potentially higher risk in terms of short-term price fluctuations for HBCNF.
HBCNF vs SPLTF Comparison
HBCNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HBCNF stands at 8.44M. In comparison, SPLTF has a market cap of 7.95M. Regarding current trading prices, HBCNF is priced at $0.50, while SPLTF trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HBCNF currently has a P/E ratio of -0.59, whereas SPLTF's P/E ratio is -2.60. In terms of profitability, HBCNF's ROE is -0.57%, compared to SPLTF's ROE of -6.63%. Regarding short-term risk, HBCNF is less volatile compared to SPLTF. This indicates potentially lower risk in terms of short-term price fluctuations for HBCNF.
HBCNF vs EMOR Comparison
HBCNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HBCNF stands at 8.44M. In comparison, EMOR has a market cap of 7.55M. Regarding current trading prices, HBCNF is priced at $0.50, while EMOR trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HBCNF currently has a P/E ratio of -0.59, whereas EMOR's P/E ratio is N/A. In terms of profitability, HBCNF's ROE is -0.57%, compared to EMOR's ROE of +0.28%. Regarding short-term risk, HBCNF is less volatile compared to EMOR. This indicates potentially lower risk in terms of short-term price fluctuations for HBCNF.
HBCNF vs CRBKF Comparison
HBCNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HBCNF stands at 8.44M. In comparison, CRBKF has a market cap of 6.84M. Regarding current trading prices, HBCNF is priced at $0.50, while CRBKF trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HBCNF currently has a P/E ratio of -0.59, whereas CRBKF's P/E ratio is -1.40. In terms of profitability, HBCNF's ROE is -0.57%, compared to CRBKF's ROE of +68.80%. Regarding short-term risk, HBCNF is more volatile compared to CRBKF. This indicates potentially higher risk in terms of short-term price fluctuations for HBCNF.
HBCNF vs DOCRF Comparison
HBCNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HBCNF stands at 8.44M. In comparison, DOCRF has a market cap of 6.25M. Regarding current trading prices, HBCNF is priced at $0.50, while DOCRF trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HBCNF currently has a P/E ratio of -0.59, whereas DOCRF's P/E ratio is -0.11. In terms of profitability, HBCNF's ROE is -0.57%, compared to DOCRF's ROE of -1.25%. Regarding short-term risk, HBCNF is more volatile compared to DOCRF. This indicates potentially higher risk in terms of short-term price fluctuations for HBCNF.
HBCNF vs CNONF Comparison
HBCNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HBCNF stands at 8.44M. In comparison, CNONF has a market cap of 4.99M. Regarding current trading prices, HBCNF is priced at $0.50, while CNONF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HBCNF currently has a P/E ratio of -0.59, whereas CNONF's P/E ratio is N/A. In terms of profitability, HBCNF's ROE is -0.57%, compared to CNONF's ROE of +1.60%. Regarding short-term risk, HBCNF is less volatile compared to CNONF. This indicates potentially lower risk in terms of short-term price fluctuations for HBCNF.
HBCNF vs RYAHF Comparison
HBCNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HBCNF stands at 8.44M. In comparison, RYAHF has a market cap of 4.96M. Regarding current trading prices, HBCNF is priced at $0.50, while RYAHF trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HBCNF currently has a P/E ratio of -0.59, whereas RYAHF's P/E ratio is 0.25. In terms of profitability, HBCNF's ROE is -0.57%, compared to RYAHF's ROE of +0.00%. Regarding short-term risk, HBCNF is more volatile compared to RYAHF. This indicates potentially higher risk in terms of short-term price fluctuations for HBCNF.
HBCNF vs CDXFF Comparison
HBCNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HBCNF stands at 8.44M. In comparison, CDXFF has a market cap of 4.83M. Regarding current trading prices, HBCNF is priced at $0.50, while CDXFF trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HBCNF currently has a P/E ratio of -0.59, whereas CDXFF's P/E ratio is -1.20. In terms of profitability, HBCNF's ROE is -0.57%, compared to CDXFF's ROE of +0.44%. Regarding short-term risk, HBCNF is less volatile compared to CDXFF. This indicates potentially lower risk in terms of short-term price fluctuations for HBCNF.
HBCNF vs MDBIF Comparison
HBCNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HBCNF stands at 8.44M. In comparison, MDBIF has a market cap of 4.75M. Regarding current trading prices, HBCNF is priced at $0.50, while MDBIF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HBCNF currently has a P/E ratio of -0.59, whereas MDBIF's P/E ratio is -0.21. In terms of profitability, HBCNF's ROE is -0.57%, compared to MDBIF's ROE of -0.14%. Regarding short-term risk, HBCNF is less volatile compared to MDBIF. This indicates potentially lower risk in terms of short-term price fluctuations for HBCNF.
HBCNF vs CMPD Comparison
HBCNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HBCNF stands at 8.44M. In comparison, CMPD has a market cap of 4.74M. Regarding current trading prices, HBCNF is priced at $0.50, while CMPD trades at $3.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HBCNF currently has a P/E ratio of -0.59, whereas CMPD's P/E ratio is -18.76. In terms of profitability, HBCNF's ROE is -0.57%, compared to CMPD's ROE of +0.07%. Regarding short-term risk, HBCNF is less volatile compared to CMPD. This indicates potentially lower risk in terms of short-term price fluctuations for HBCNF.
HBCNF vs CBDS Comparison
HBCNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HBCNF stands at 8.44M. In comparison, CBDS has a market cap of 4.36M. Regarding current trading prices, HBCNF is priced at $0.50, while CBDS trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HBCNF currently has a P/E ratio of -0.59, whereas CBDS's P/E ratio is -1.53. In terms of profitability, HBCNF's ROE is -0.57%, compared to CBDS's ROE of +1.55%. Regarding short-term risk, HBCNF is less volatile compared to CBDS. This indicates potentially lower risk in terms of short-term price fluctuations for HBCNF.
HBCNF vs IQAIF Comparison
HBCNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HBCNF stands at 8.44M. In comparison, IQAIF has a market cap of 4.19M. Regarding current trading prices, HBCNF is priced at $0.50, while IQAIF trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HBCNF currently has a P/E ratio of -0.59, whereas IQAIF's P/E ratio is N/A. In terms of profitability, HBCNF's ROE is -0.57%, compared to IQAIF's ROE of -1.62%. Regarding short-term risk, HBCNF is less volatile compared to IQAIF. This indicates potentially lower risk in terms of short-term price fluctuations for HBCNF.
HBCNF vs MITI Comparison
HBCNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HBCNF stands at 8.44M. In comparison, MITI has a market cap of 3.39M. Regarding current trading prices, HBCNF is priced at $0.50, while MITI trades at $0.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HBCNF currently has a P/E ratio of -0.59, whereas MITI's P/E ratio is -0.71. In terms of profitability, HBCNF's ROE is -0.57%, compared to MITI's ROE of -0.05%. Regarding short-term risk, HBCNF is more volatile compared to MITI. This indicates potentially higher risk in terms of short-term price fluctuations for HBCNF.
HBCNF vs CMHSF Comparison
HBCNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HBCNF stands at 8.44M. In comparison, CMHSF has a market cap of 2.17M. Regarding current trading prices, HBCNF is priced at $0.50, while CMHSF trades at $0.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HBCNF currently has a P/E ratio of -0.59, whereas CMHSF's P/E ratio is 1.00. In terms of profitability, HBCNF's ROE is -0.57%, compared to CMHSF's ROE of +0.10%. Regarding short-term risk, HBCNF is less volatile compared to CMHSF. This indicates potentially lower risk in terms of short-term price fluctuations for HBCNF.
HBCNF vs EKGGF Comparison
HBCNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HBCNF stands at 8.44M. In comparison, EKGGF has a market cap of 1.97M. Regarding current trading prices, HBCNF is priced at $0.50, while EKGGF trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HBCNF currently has a P/E ratio of -0.59, whereas EKGGF's P/E ratio is N/A. In terms of profitability, HBCNF's ROE is -0.57%, compared to EKGGF's ROE of +0.54%. Regarding short-term risk, HBCNF is less volatile compared to EKGGF. This indicates potentially lower risk in terms of short-term price fluctuations for HBCNF.
HBCNF vs CSOC Comparison
HBCNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HBCNF stands at 8.44M. In comparison, CSOC has a market cap of 1.94M. Regarding current trading prices, HBCNF is priced at $0.50, while CSOC trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HBCNF currently has a P/E ratio of -0.59, whereas CSOC's P/E ratio is 0.35. In terms of profitability, HBCNF's ROE is -0.57%, compared to CSOC's ROE of -2.38%. Regarding short-term risk, HBCNF is more volatile compared to CSOC. This indicates potentially higher risk in terms of short-term price fluctuations for HBCNF.
HBCNF vs EBYH Comparison
HBCNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HBCNF stands at 8.44M. In comparison, EBYH has a market cap of 1.89M. Regarding current trading prices, HBCNF is priced at $0.50, while EBYH trades at $0.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HBCNF currently has a P/E ratio of -0.59, whereas EBYH's P/E ratio is -5.43. In terms of profitability, HBCNF's ROE is -0.57%, compared to EBYH's ROE of -0.03%. Regarding short-term risk, HBCNF is more volatile compared to EBYH. This indicates potentially higher risk in terms of short-term price fluctuations for HBCNF.
HBCNF vs BNVIF Comparison
HBCNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HBCNF stands at 8.44M. In comparison, BNVIF has a market cap of 1.68M. Regarding current trading prices, HBCNF is priced at $0.50, while BNVIF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HBCNF currently has a P/E ratio of -0.59, whereas BNVIF's P/E ratio is N/A. In terms of profitability, HBCNF's ROE is -0.57%, compared to BNVIF's ROE of -4.34%. Regarding short-term risk, HBCNF is less volatile compared to BNVIF. This indicates potentially lower risk in terms of short-term price fluctuations for HBCNF.
HBCNF vs LVCE Comparison
HBCNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HBCNF stands at 8.44M. In comparison, LVCE has a market cap of 1.35M. Regarding current trading prices, HBCNF is priced at $0.50, while LVCE trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HBCNF currently has a P/E ratio of -0.59, whereas LVCE's P/E ratio is N/A. In terms of profitability, HBCNF's ROE is -0.57%, compared to LVCE's ROE of N/A. Regarding short-term risk, HBCNF is less volatile compared to LVCE. This indicates potentially lower risk in terms of short-term price fluctuations for HBCNF.
HBCNF vs CTVEF Comparison
HBCNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HBCNF stands at 8.44M. In comparison, CTVEF has a market cap of 1.21M. Regarding current trading prices, HBCNF is priced at $0.50, while CTVEF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HBCNF currently has a P/E ratio of -0.59, whereas CTVEF's P/E ratio is -0.23. In terms of profitability, HBCNF's ROE is -0.57%, compared to CTVEF's ROE of +0.08%. Regarding short-term risk, HBCNF is more volatile compared to CTVEF. This indicates potentially higher risk in terms of short-term price fluctuations for HBCNF.
HBCNF vs MDXL Comparison
HBCNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HBCNF stands at 8.44M. In comparison, MDXL has a market cap of 845013.00. Regarding current trading prices, HBCNF is priced at $0.50, while MDXL trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HBCNF currently has a P/E ratio of -0.59, whereas MDXL's P/E ratio is -0.10. In terms of profitability, HBCNF's ROE is -0.57%, compared to MDXL's ROE of +0.90%. Regarding short-term risk, HBCNF is less volatile compared to MDXL. This indicates potentially lower risk in terms of short-term price fluctuations for HBCNF.
HBCNF vs CGNSF Comparison
HBCNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HBCNF stands at 8.44M. In comparison, CGNSF has a market cap of 641096.00. Regarding current trading prices, HBCNF is priced at $0.50, while CGNSF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HBCNF currently has a P/E ratio of -0.59, whereas CGNSF's P/E ratio is N/A. In terms of profitability, HBCNF's ROE is -0.57%, compared to CGNSF's ROE of +0.96%. Regarding short-term risk, HBCNF is less volatile compared to CGNSF. This indicates potentially lower risk in terms of short-term price fluctuations for HBCNF.
HBCNF vs NEWUF Comparison
HBCNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HBCNF stands at 8.44M. In comparison, NEWUF has a market cap of 620298.00. Regarding current trading prices, HBCNF is priced at $0.50, while NEWUF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HBCNF currently has a P/E ratio of -0.59, whereas NEWUF's P/E ratio is N/A. In terms of profitability, HBCNF's ROE is -0.57%, compared to NEWUF's ROE of +0.67%. Regarding short-term risk, HBCNF is less volatile compared to NEWUF. This indicates potentially lower risk in terms of short-term price fluctuations for HBCNF.
HBCNF vs DTRK Comparison
HBCNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HBCNF stands at 8.44M. In comparison, DTRK has a market cap of 587880.00. Regarding current trading prices, HBCNF is priced at $0.50, while DTRK trades at $0.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HBCNF currently has a P/E ratio of -0.59, whereas DTRK's P/E ratio is -4.18. In terms of profitability, HBCNF's ROE is -0.57%, compared to DTRK's ROE of -9.79%. Regarding short-term risk, HBCNF is more volatile compared to DTRK. This indicates potentially higher risk in terms of short-term price fluctuations for HBCNF.
HBCNF vs EVAHF Comparison
HBCNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HBCNF stands at 8.44M. In comparison, EVAHF has a market cap of 545985.00. Regarding current trading prices, HBCNF is priced at $0.50, while EVAHF trades at $0.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HBCNF currently has a P/E ratio of -0.59, whereas EVAHF's P/E ratio is -4.70. In terms of profitability, HBCNF's ROE is -0.57%, compared to EVAHF's ROE of +0.29%. Regarding short-term risk, HBCNF is less volatile compared to EVAHF. This indicates potentially lower risk in terms of short-term price fluctuations for HBCNF.
HBCNF vs MDRM Comparison
HBCNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HBCNF stands at 8.44M. In comparison, MDRM has a market cap of 522947.00. Regarding current trading prices, HBCNF is priced at $0.50, while MDRM trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HBCNF currently has a P/E ratio of -0.59, whereas MDRM's P/E ratio is -0.41. In terms of profitability, HBCNF's ROE is -0.57%, compared to MDRM's ROE of +0.42%. Regarding short-term risk, HBCNF is more volatile compared to MDRM. This indicates potentially higher risk in terms of short-term price fluctuations for HBCNF.
HBCNF vs ACHKF Comparison
HBCNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HBCNF stands at 8.44M. In comparison, ACHKF has a market cap of 522554.00. Regarding current trading prices, HBCNF is priced at $0.50, while ACHKF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HBCNF currently has a P/E ratio of -0.59, whereas ACHKF's P/E ratio is -0.07. In terms of profitability, HBCNF's ROE is -0.57%, compared to ACHKF's ROE of +2.16%. Regarding short-term risk, HBCNF is less volatile compared to ACHKF. This indicates potentially lower risk in terms of short-term price fluctuations for HBCNF.
HBCNF vs MDNWF Comparison
HBCNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HBCNF stands at 8.44M. In comparison, MDNWF has a market cap of 517288.00. Regarding current trading prices, HBCNF is priced at $0.50, while MDNWF trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HBCNF currently has a P/E ratio of -0.59, whereas MDNWF's P/E ratio is -0.02. In terms of profitability, HBCNF's ROE is -0.57%, compared to MDNWF's ROE of -1.53%. Regarding short-term risk, HBCNF is less volatile compared to MDNWF. This indicates potentially lower risk in terms of short-term price fluctuations for HBCNF.
HBCNF vs NDATF Comparison
HBCNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HBCNF stands at 8.44M. In comparison, NDATF has a market cap of 450469.00. Regarding current trading prices, HBCNF is priced at $0.50, while NDATF trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HBCNF currently has a P/E ratio of -0.59, whereas NDATF's P/E ratio is -0.55. In terms of profitability, HBCNF's ROE is -0.57%, compared to NDATF's ROE of -0.62%. Regarding short-term risk, HBCNF is more volatile compared to NDATF. This indicates potentially higher risk in terms of short-term price fluctuations for HBCNF.
HBCNF vs LFCOF Comparison
HBCNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HBCNF stands at 8.44M. In comparison, LFCOF has a market cap of 281984.00. Regarding current trading prices, HBCNF is priced at $0.50, while LFCOF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HBCNF currently has a P/E ratio of -0.59, whereas LFCOF's P/E ratio is -0.04. In terms of profitability, HBCNF's ROE is -0.57%, compared to LFCOF's ROE of +8.70%. Regarding short-term risk, HBCNF is less volatile compared to LFCOF. This indicates potentially lower risk in terms of short-term price fluctuations for HBCNF.
HBCNF vs TSTTF Comparison
HBCNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HBCNF stands at 8.44M. In comparison, TSTTF has a market cap of 190693.00. Regarding current trading prices, HBCNF is priced at $0.50, while TSTTF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HBCNF currently has a P/E ratio of -0.59, whereas TSTTF's P/E ratio is -0.07. In terms of profitability, HBCNF's ROE is -0.57%, compared to TSTTF's ROE of +0.33%. Regarding short-term risk, HBCNF is less volatile compared to TSTTF. This indicates potentially lower risk in terms of short-term price fluctuations for HBCNF.
HBCNF vs EWLL Comparison
HBCNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HBCNF stands at 8.44M. In comparison, EWLL has a market cap of 185077.00. Regarding current trading prices, HBCNF is priced at $0.50, while EWLL trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HBCNF currently has a P/E ratio of -0.59, whereas EWLL's P/E ratio is N/A. In terms of profitability, HBCNF's ROE is -0.57%, compared to EWLL's ROE of +0.00%. Regarding short-term risk, HBCNF is less volatile compared to EWLL. This indicates potentially lower risk in terms of short-term price fluctuations for HBCNF.
HBCNF vs ALDNF Comparison
HBCNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HBCNF stands at 8.44M. In comparison, ALDNF has a market cap of 160415.00. Regarding current trading prices, HBCNF is priced at $0.50, while ALDNF trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HBCNF currently has a P/E ratio of -0.59, whereas ALDNF's P/E ratio is N/A. In terms of profitability, HBCNF's ROE is -0.57%, compared to ALDNF's ROE of +0.00%. Regarding short-term risk, HBCNF is more volatile compared to ALDNF. This indicates potentially higher risk in terms of short-term price fluctuations for HBCNF.
HBCNF vs USPS Comparison
HBCNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HBCNF stands at 8.44M. In comparison, USPS has a market cap of 158503.00. Regarding current trading prices, HBCNF is priced at $0.50, while USPS trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HBCNF currently has a P/E ratio of -0.59, whereas USPS's P/E ratio is -1.00. In terms of profitability, HBCNF's ROE is -0.57%, compared to USPS's ROE of N/A. Regarding short-term risk, HBCNF is less volatile compared to USPS. This indicates potentially lower risk in terms of short-term price fluctuations for HBCNF.
HBCNF vs EMYSF Comparison
HBCNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HBCNF stands at 8.44M. In comparison, EMYSF has a market cap of 151670.00. Regarding current trading prices, HBCNF is priced at $0.50, while EMYSF trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HBCNF currently has a P/E ratio of -0.59, whereas EMYSF's P/E ratio is N/A. In terms of profitability, HBCNF's ROE is -0.57%, compared to EMYSF's ROE of +0.00%. Regarding short-term risk, HBCNF is less volatile compared to EMYSF. This indicates potentially lower risk in terms of short-term price fluctuations for HBCNF.
HBCNF vs NMXS Comparison
HBCNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HBCNF stands at 8.44M. In comparison, NMXS has a market cap of 116770.00. Regarding current trading prices, HBCNF is priced at $0.50, while NMXS trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HBCNF currently has a P/E ratio of -0.59, whereas NMXS's P/E ratio is -0.31. In terms of profitability, HBCNF's ROE is -0.57%, compared to NMXS's ROE of +1.59%. Regarding short-term risk, HBCNF is more volatile compared to NMXS. This indicates potentially higher risk in terms of short-term price fluctuations for HBCNF.
HBCNF vs PPJE Comparison
HBCNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HBCNF stands at 8.44M. In comparison, PPJE has a market cap of 92048.00. Regarding current trading prices, HBCNF is priced at $0.50, while PPJE trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HBCNF currently has a P/E ratio of -0.59, whereas PPJE's P/E ratio is N/A. In terms of profitability, HBCNF's ROE is -0.57%, compared to PPJE's ROE of +0.00%. Regarding short-term risk, HBCNF is less volatile compared to PPJE. This indicates potentially lower risk in terms of short-term price fluctuations for HBCNF.
HBCNF vs DSOL Comparison
HBCNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HBCNF stands at 8.44M. In comparison, DSOL has a market cap of 88891.00. Regarding current trading prices, HBCNF is priced at $0.50, while DSOL trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HBCNF currently has a P/E ratio of -0.59, whereas DSOL's P/E ratio is N/A. In terms of profitability, HBCNF's ROE is -0.57%, compared to DSOL's ROE of +0.05%. Regarding short-term risk, HBCNF is more volatile compared to DSOL. This indicates potentially higher risk in terms of short-term price fluctuations for HBCNF.
HBCNF vs PASO Comparison
HBCNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HBCNF stands at 8.44M. In comparison, PASO has a market cap of 74059.00. Regarding current trading prices, HBCNF is priced at $0.50, while PASO trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HBCNF currently has a P/E ratio of -0.59, whereas PASO's P/E ratio is N/A. In terms of profitability, HBCNF's ROE is -0.57%, compared to PASO's ROE of +6.20%. Regarding short-term risk, HBCNF is more volatile compared to PASO. This indicates potentially higher risk in terms of short-term price fluctuations for HBCNF.
HBCNF vs ICCO Comparison
HBCNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HBCNF stands at 8.44M. In comparison, ICCO has a market cap of 71654.00. Regarding current trading prices, HBCNF is priced at $0.50, while ICCO trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HBCNF currently has a P/E ratio of -0.59, whereas ICCO's P/E ratio is -0.40. In terms of profitability, HBCNF's ROE is -0.57%, compared to ICCO's ROE of +0.17%. Regarding short-term risk, HBCNF is less volatile compared to ICCO. This indicates potentially lower risk in terms of short-term price fluctuations for HBCNF.
HBCNF vs REFG Comparison
HBCNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HBCNF stands at 8.44M. In comparison, REFG has a market cap of 60838.00. Regarding current trading prices, HBCNF is priced at $0.50, while REFG trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HBCNF currently has a P/E ratio of -0.59, whereas REFG's P/E ratio is -0.01. In terms of profitability, HBCNF's ROE is -0.57%, compared to REFG's ROE of +0.01%. Regarding short-term risk, HBCNF is more volatile compared to REFG. This indicates potentially higher risk in terms of short-term price fluctuations for HBCNF.
HBCNF vs SOFE Comparison
HBCNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HBCNF stands at 8.44M. In comparison, SOFE has a market cap of 45131.00. Regarding current trading prices, HBCNF is priced at $0.50, while SOFE trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HBCNF currently has a P/E ratio of -0.59, whereas SOFE's P/E ratio is N/A. In terms of profitability, HBCNF's ROE is -0.57%, compared to SOFE's ROE of +0.52%. Regarding short-term risk, HBCNF is less volatile compared to SOFE. This indicates potentially lower risk in terms of short-term price fluctuations for HBCNF.
HBCNF vs HDVY Comparison
HBCNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HBCNF stands at 8.44M. In comparison, HDVY has a market cap of 41171.00. Regarding current trading prices, HBCNF is priced at $0.50, while HDVY trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HBCNF currently has a P/E ratio of -0.59, whereas HDVY's P/E ratio is N/A. In terms of profitability, HBCNF's ROE is -0.57%, compared to HDVY's ROE of +0.00%. Regarding short-term risk, HBCNF is more volatile compared to HDVY. This indicates potentially higher risk in terms of short-term price fluctuations for HBCNF.
HBCNF vs IGRW Comparison
HBCNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HBCNF stands at 8.44M. In comparison, IGRW has a market cap of 39815.00. Regarding current trading prices, HBCNF is priced at $0.50, while IGRW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HBCNF currently has a P/E ratio of -0.59, whereas IGRW's P/E ratio is -0.00. In terms of profitability, HBCNF's ROE is -0.57%, compared to IGRW's ROE of +7.88%. Regarding short-term risk, HBCNF is less volatile compared to IGRW. This indicates potentially lower risk in terms of short-term price fluctuations for HBCNF.
HBCNF vs SSYNF Comparison
HBCNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HBCNF stands at 8.44M. In comparison, SSYNF has a market cap of 33293.00. Regarding current trading prices, HBCNF is priced at $0.50, while SSYNF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HBCNF currently has a P/E ratio of -0.59, whereas SSYNF's P/E ratio is -0.00. In terms of profitability, HBCNF's ROE is -0.57%, compared to SSYNF's ROE of N/A. Regarding short-term risk, HBCNF is more volatile compared to SSYNF. This indicates potentially higher risk in terms of short-term price fluctuations for HBCNF.
HBCNF vs RVRC Comparison
HBCNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HBCNF stands at 8.44M. In comparison, RVRC has a market cap of 31411.00. Regarding current trading prices, HBCNF is priced at $0.50, while RVRC trades at $0.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HBCNF currently has a P/E ratio of -0.59, whereas RVRC's P/E ratio is -0.09. In terms of profitability, HBCNF's ROE is -0.57%, compared to RVRC's ROE of -0.29%. Regarding short-term risk, HBCNF is less volatile compared to RVRC. This indicates potentially lower risk in terms of short-term price fluctuations for HBCNF.
HBCNF vs TTBLF Comparison
HBCNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HBCNF stands at 8.44M. In comparison, TTBLF has a market cap of 26744.00. Regarding current trading prices, HBCNF is priced at $0.50, while TTBLF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HBCNF currently has a P/E ratio of -0.59, whereas TTBLF's P/E ratio is -0.00. In terms of profitability, HBCNF's ROE is -0.57%, compared to TTBLF's ROE of -1.03%. Regarding short-term risk, HBCNF is less volatile compared to TTBLF. This indicates potentially lower risk in terms of short-term price fluctuations for HBCNF.
HBCNF vs ORHB Comparison
HBCNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HBCNF stands at 8.44M. In comparison, ORHB has a market cap of 25558.00. Regarding current trading prices, HBCNF is priced at $0.50, while ORHB trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HBCNF currently has a P/E ratio of -0.59, whereas ORHB's P/E ratio is -0.01. In terms of profitability, HBCNF's ROE is -0.57%, compared to ORHB's ROE of +0.33%. Regarding short-term risk, HBCNF is more volatile compared to ORHB. This indicates potentially higher risk in terms of short-term price fluctuations for HBCNF.
HBCNF vs NHEL Comparison
HBCNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HBCNF stands at 8.44M. In comparison, NHEL has a market cap of 16219.00. Regarding current trading prices, HBCNF is priced at $0.50, while NHEL trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HBCNF currently has a P/E ratio of -0.59, whereas NHEL's P/E ratio is N/A. In terms of profitability, HBCNF's ROE is -0.57%, compared to NHEL's ROE of +0.00%. Regarding short-term risk, HBCNF is more volatile compared to NHEL. This indicates potentially higher risk in terms of short-term price fluctuations for HBCNF.
HBCNF vs FDBH Comparison
HBCNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HBCNF stands at 8.44M. In comparison, FDBH has a market cap of 15022.00. Regarding current trading prices, HBCNF is priced at $0.50, while FDBH trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HBCNF currently has a P/E ratio of -0.59, whereas FDBH's P/E ratio is N/A. In terms of profitability, HBCNF's ROE is -0.57%, compared to FDBH's ROE of +0.32%. Regarding short-term risk, HBCNF is more volatile compared to FDBH. This indicates potentially higher risk in terms of short-term price fluctuations for HBCNF.
HBCNF vs HLTT Comparison
HBCNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HBCNF stands at 8.44M. In comparison, HLTT has a market cap of 10663.00. Regarding current trading prices, HBCNF is priced at $0.50, while HLTT trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HBCNF currently has a P/E ratio of -0.59, whereas HLTT's P/E ratio is N/A. In terms of profitability, HBCNF's ROE is -0.57%, compared to HLTT's ROE of +1789941.38%. Regarding short-term risk, HBCNF is more volatile compared to HLTT. This indicates potentially higher risk in terms of short-term price fluctuations for HBCNF.
HBCNF vs MOSTQ Comparison
HBCNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HBCNF stands at 8.44M. In comparison, MOSTQ has a market cap of 8517.00. Regarding current trading prices, HBCNF is priced at $0.50, while MOSTQ trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HBCNF currently has a P/E ratio of -0.59, whereas MOSTQ's P/E ratio is N/A. In terms of profitability, HBCNF's ROE is -0.57%, compared to MOSTQ's ROE of +2.26%. Regarding short-term risk, HBCNF is more volatile compared to MOSTQ. This indicates potentially higher risk in terms of short-term price fluctuations for HBCNF.
HBCNF vs AHGIF Comparison
HBCNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HBCNF stands at 8.44M. In comparison, AHGIF has a market cap of 7789.00. Regarding current trading prices, HBCNF is priced at $0.50, while AHGIF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HBCNF currently has a P/E ratio of -0.59, whereas AHGIF's P/E ratio is N/A. In terms of profitability, HBCNF's ROE is -0.57%, compared to AHGIF's ROE of -2.79%. Regarding short-term risk, HBCNF is less volatile compared to AHGIF. This indicates potentially lower risk in terms of short-term price fluctuations for HBCNF.
HBCNF vs NHIQ Comparison
HBCNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HBCNF stands at 8.44M. In comparison, NHIQ has a market cap of 2747.00. Regarding current trading prices, HBCNF is priced at $0.50, while NHIQ trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HBCNF currently has a P/E ratio of -0.59, whereas NHIQ's P/E ratio is N/A. In terms of profitability, HBCNF's ROE is -0.57%, compared to NHIQ's ROE of +0.35%. Regarding short-term risk, HBCNF is less volatile compared to NHIQ. This indicates potentially lower risk in terms of short-term price fluctuations for HBCNF.
HBCNF vs BBLNF Comparison
HBCNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HBCNF stands at 8.44M. In comparison, BBLNF has a market cap of 2561.00. Regarding current trading prices, HBCNF is priced at $0.50, while BBLNF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HBCNF currently has a P/E ratio of -0.59, whereas BBLNF's P/E ratio is N/A. In terms of profitability, HBCNF's ROE is -0.57%, compared to BBLNF's ROE of +1.06%. Regarding short-term risk, HBCNF is more volatile compared to BBLNF. This indicates potentially higher risk in terms of short-term price fluctuations for HBCNF.
HBCNF vs PCYS Comparison
HBCNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HBCNF stands at 8.44M. In comparison, PCYS has a market cap of 1105.00. Regarding current trading prices, HBCNF is priced at $0.50, while PCYS trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HBCNF currently has a P/E ratio of -0.59, whereas PCYS's P/E ratio is N/A. In terms of profitability, HBCNF's ROE is -0.57%, compared to PCYS's ROE of N/A. Regarding short-term risk, HBCNF is less volatile compared to PCYS. This indicates potentially lower risk in terms of short-term price fluctuations for HBCNF.
HBCNF vs OLMM Comparison
HBCNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HBCNF stands at 8.44M. In comparison, OLMM has a market cap of 1005.00. Regarding current trading prices, HBCNF is priced at $0.50, while OLMM trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HBCNF currently has a P/E ratio of -0.59, whereas OLMM's P/E ratio is N/A. In terms of profitability, HBCNF's ROE is -0.57%, compared to OLMM's ROE of +0.00%. Regarding short-term risk, HBCNF is less volatile compared to OLMM. This indicates potentially lower risk in terms of short-term price fluctuations for HBCNF.
HBCNF vs ACNV Comparison
HBCNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HBCNF stands at 8.44M. In comparison, ACNV has a market cap of 814.00. Regarding current trading prices, HBCNF is priced at $0.50, while ACNV trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HBCNF currently has a P/E ratio of -0.59, whereas ACNV's P/E ratio is N/A. In terms of profitability, HBCNF's ROE is -0.57%, compared to ACNV's ROE of +0.00%. Regarding short-term risk, HBCNF is less volatile compared to ACNV. This indicates potentially lower risk in terms of short-term price fluctuations for HBCNF.
HBCNF vs ETAOF Comparison
HBCNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HBCNF stands at 8.44M. In comparison, ETAOF has a market cap of 512.00. Regarding current trading prices, HBCNF is priced at $0.50, while ETAOF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HBCNF currently has a P/E ratio of -0.59, whereas ETAOF's P/E ratio is N/A. In terms of profitability, HBCNF's ROE is -0.57%, compared to ETAOF's ROE of -13.69%. Regarding short-term risk, HBCNF is less volatile compared to ETAOF. This indicates potentially lower risk in terms of short-term price fluctuations for HBCNF.
HBCNF vs WMGR Comparison
HBCNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HBCNF stands at 8.44M. In comparison, WMGR has a market cap of 363.00. Regarding current trading prices, HBCNF is priced at $0.50, while WMGR trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HBCNF currently has a P/E ratio of -0.59, whereas WMGR's P/E ratio is N/A. In terms of profitability, HBCNF's ROE is -0.57%, compared to WMGR's ROE of +0.00%. Regarding short-term risk, HBCNF is more volatile compared to WMGR. This indicates potentially higher risk in terms of short-term price fluctuations for HBCNF.
HBCNF vs LGBI Comparison
HBCNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HBCNF stands at 8.44M. In comparison, LGBI has a market cap of 50.00. Regarding current trading prices, HBCNF is priced at $0.50, while LGBI trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HBCNF currently has a P/E ratio of -0.59, whereas LGBI's P/E ratio is N/A. In terms of profitability, HBCNF's ROE is -0.57%, compared to LGBI's ROE of +0.00%. Regarding short-term risk, HBCNF is less volatile compared to LGBI. This indicates potentially lower risk in terms of short-term price fluctuations for HBCNF.
HBCNF vs APYI Comparison
HBCNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HBCNF stands at 8.44M. In comparison, APYI has a market cap of 34.00. Regarding current trading prices, HBCNF is priced at $0.50, while APYI trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HBCNF currently has a P/E ratio of -0.59, whereas APYI's P/E ratio is N/A. In terms of profitability, HBCNF's ROE is -0.57%, compared to APYI's ROE of -0.60%. Regarding short-term risk, HBCNF is more volatile compared to APYI. This indicates potentially higher risk in terms of short-term price fluctuations for HBCNF.